Form 4/A for PGNY Progyny, Inc.
Accepted 2023-02-06 00:00:00 ET · period of report 2022-06-27 · accession 0001628280-23-002435 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2023-02-06 | 2022-06-27 | PGNY | Schlanger David J | Executive COB, Dir | M - OptEx | $0.91 | +1,452 | 85.5K | +2% | +$1,321 |
| DA | 2023-02-06 | 2022-06-27 | PGNY | Schlanger David J | Executive COB, Dir | M - OptEx | $0.00 | -1,452 | 1.73M | -0.1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-27 | M | A | 1,452 | $0.91 | 85,452 | D | — | — | (F1) This Form 4/A is being filed to reflect the stock option exercise reported in Table II, which was inadvertently omitted from the original Form 4 filing (the "Original Filing"). The total securities reported in Column 5 of Table I has also been updated to reflect the number of shares of common stock held by the Reporting Person as of June 29, 2022, the date of the Original Filing. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-06-27 | M | D | 1,452 | $0.00 | 1,732,228 | D | $0.91 · — to 2027-08-03 | 1,452 Common Stock | (F4) The amount reported in Column 9 of Table II has been updated to reflect the number of derivative securities held by the Reporting Person as of the date of the Original Filing. (F3) These options are fully vested and exercisable. |